| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/14/2011 | CA2781223A1 Combination preparation including a cytokine antagonist and corticosteroid |
| 07/13/2011 | EP2343372A1 Method for predicting pharmacological efficacy of anti-tnf antibody preparation on rheumatoid arthritis, and pharmacological efficacy prediction apparatus |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/13/2011 | EP2343072A1 Remedy |
| 07/13/2011 | EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 07/13/2011 | EP2342976A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342974A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342205A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 07/13/2011 | EP2342200A2 Compounds which selectively modulate the cb2 receptor |
| 07/13/2011 | EP2342199A2 Compounds which selectively modulate the cb2 receptor |
| 07/13/2011 | EP2342177A1 Novel potassium channel blockers |
| 07/13/2011 | EP2341939A2 Dendritic cell modulatory molecule |
| 07/13/2011 | EP2341915A1 Phosphorylated dendrimers as antiinflammatory drugs |
| 07/13/2011 | EP2341913A1 Method of enhancing tgf-beta signalling |
| 07/13/2011 | EP2341900A1 A medicinal product and treatment |
| 07/13/2011 | EP1844032B1 N-hydroxyamide derivatives and use thereof |
| 07/13/2011 | EP1714976B1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage |
| 07/13/2011 | EP1578741B1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 07/13/2011 | EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 07/13/2011 | CN102124009A Kinase inhibitors and methods of use |
| 07/13/2011 | CN102124006A Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 07/13/2011 | CN102124001A Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 07/13/2011 | CN102123995A Phenyl-alkyl piperazines having a modulating activity of tnf |
| 07/13/2011 | CN102123993A Imine derivatives as cannabinoid receptor ligands |
| 07/13/2011 | CN102123992A Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 07/13/2011 | CN102123986A Pharmaceutical compositions |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102121170A Preparation of effect component fibers of edgoworthia chriysantha lind and application thereof |
| 07/13/2011 | CN102121023A Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/13/2011 | CN102120752A Compound with effects of resisting inflammation and platelet activation and aggregation as well as preparation method and application thereof |
| 07/13/2011 | CN102120740A Imidazoline compound chirally synthesized by using thiourea catalyst derived from rosin and application thereof in anti-inflammatory and antipyretic aspects |
| 07/13/2011 | CN102120022A Medicament for treating pain and fever caused by cancer |
| 07/13/2011 | CN102120013A Tea for clearing damp and removing arthritis |
| 07/13/2011 | CN102119994A Traditional Chinese medicine enema for treating exogenous fever of infants |
| 07/13/2011 | CN102119990A Chinese medicinal preparation for nourishing liver and kidney, supplementing qi, engendering blood, promoting blood circulation, removing obstruction in channels and relieving pain |
| 07/13/2011 | CN102119989A Traditional Chinese medicine capsule for treating lumbar intervertebral disc protrusion, hyperosteogeny, periarthritis humeroscapularis, arthritis and cervical spondylosis |
| 07/13/2011 | CN102119988A Traditional Chinese medicine preparation for activating blood circulation to dissipate blood stasis |
| 07/13/2011 | CN102119973A Quality control method for gardenia percolate |
| 07/13/2011 | CN102119968A Method for processing and preparing fresh rhizoma corydalis |
| 07/13/2011 | CN102119954A Application of glycine tomentella hayata. root and extract thereof in preparing medicament for treating rheumatoid arthritis |
| 07/13/2011 | CN102119952A Ultrasonic extraction preparation method of Chinese traditional medicine preparation for treating lumbago due to kidney deficiency |
| 07/13/2011 | CN102119918A Medicinal sustained-release preparation for treating osteomyelitis and preparation method and application thereof |
| 07/13/2011 | CN102119821A Health-protecting material, application thereof in preparing health-protecting pillow and cushion, and health-protecting pillow and cushion |
| 07/13/2011 | CN101716142B Nimesulide injection for livestock and preparation method thereof |
| 07/13/2011 | CN101690739B Preparation method of dogbane leaf extractive |
| 07/13/2011 | CN101624352B Method for processing acetaminophen refined mother liquid |
| 07/13/2011 | CN101518644B Application of Ang-2 and genes thereof in pharmacy |
| 07/13/2011 | CN101301303B Uses of puerarin and derivatives thereof in preparing medicament |
| 07/12/2011 | US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders |
| 07/12/2011 | US7977464 Antibody molecules specific to human tumour necrosis factor alpha |
| 07/12/2011 | US7977387 Aminobenzophenone compounds |
| 07/12/2011 | US7977350 CCR1 antagonists and methods of use therefor |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | US7975690 Nasal devices |
| 07/12/2011 | CA2500113C Therapeutic piperazine compounds |
| 07/12/2011 | CA2499492C Methods of preparing cannabinoids from plant material |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2481268C Medicaments comprising steroids and a novel anticholinergic |
| 07/12/2011 | CA2475704C Colonic release formulations of prednisolone sodium metasulphobenzoate coated with amylose, ethyl cellulose and dibutyl sebacate |
| 07/12/2011 | CA2463616C Affinity enhancement agents |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2393312C Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 07/12/2011 | CA2389685C Novel heterocyclic compounds and their use as medicaments |
| 07/12/2011 | CA2352286C Intracellular targeted delivery of compounds by 70 kd heat shock protein |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/07/2011 | WO2011082290A2 Formulations from natural products, turmeric, and aspirin |
| 07/07/2011 | WO2011082245A2 Metalloenzyme inhibitor compounds |
| 07/07/2011 | WO2011082175A2 Glycosaminoglycan inhibitors |
| 07/07/2011 | WO2011082106A1 Compositions including ginger for the amelioration or prevention of inflammatory conditions |
| 07/07/2011 | WO2011081489A2 Composition for treating allergic diseases, using wheat bran extract or active ingredient isolated therefrom |
| 07/07/2011 | WO2011081465A2 Pharmaceutical composition for suppression of vascularization |
| 07/07/2011 | WO2011081445A2 Treatment use of ethylamino benzoic acid derivatives |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011021833A3 Composition for preventing or treating inflammation |
| 07/07/2011 | WO2010136766A3 Use of nlee for the treatment of autoimmune and inflammatory disorders, targetting nf - kappa b |
| 07/07/2011 | WO2010067007A3 Synthesis of morphine-6-glucuronide or one of the derivatives thereof |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166212 Gene expression and pain |
| 07/07/2011 | US20110166177 Bis-quaternary ammonium salts as pain modulating agents |
| 07/07/2011 | US20110166173 3,5-disubstututed 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors |
| 07/07/2011 | US20110166171 Sustained release monoeximic formulations of opioid and nonopioid analgesics |
| 07/07/2011 | US20110166168 Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments |
| 07/07/2011 | US20110166155 Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators |
| 07/07/2011 | US20110166153 Protein Kinase Targeted Therapeutics |
| 07/07/2011 | US20110166142 2-substituted isoflavonoid compounds, medicaments and uses |
| 07/07/2011 | US20110166140 Novel sulphonylpyrroles |
| 07/07/2011 | US20110166138 Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase for Modulation of Cannabinoid Receptors |
| 07/07/2011 | US20110166136 Calcium Ion Channel Modulators & Uses Thereof |
| 07/07/2011 | US20110166125 Substituted amides, manufacturing and use thereof as medicaments |
| 07/07/2011 | US20110166124 Tricyclic spirocycle derivatives and methods of use |
| 07/07/2011 | US20110166122 SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINE COMPOUNDS AS TRK KINASE INHIBITORS |
| 07/07/2011 | US20110166110 Fused Ring Azadecalin Glucocorticoid Receptor Modulators |
| 07/07/2011 | US20110166093 Use of adenosine receptor agonists in therapy |
| 07/07/2011 | US20110166083 Peptide analogues, particularly for the treatment of chronic pain |